SSGJ-608
SSGJ-608 is a humanized monoclonal antibody targeting IL-17A. SSGJ-608 can be used in the research of autoimmune and inflammatory diseases, such as moderate-to-severe plaque psoriasis[1].
Product Specifications
UNSPSC
12352203
Target
Interleukin Related
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
References & Citations
[1]Crescioli S, et al. Antibodies to watch in 2025. MAbs. 2025 Dec;17 (1) :2443538.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Isoform
IL-17
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
